Biotechnology Venture Capital Firms
The world of biotechnology is one filled with unlimited potential and opportunities. Built upon transformative innovations that have the strength to redefine industries, it comes as no surprise that it stands as a powerful magnet for venture capital (VC) firms keen on investing in the future. Welcome to VC Firms List, the one-stop destination for all detailed information on biotechnology venture capital firms. As you explore, you will discover why we are the go-to website for anyone seeking insights into the VC firms and investors specializing in the biotechnology sector.
Read more
Company:
Catalys Pacific
Description: Catalys Pacific is a prominent venture capital and private equity firm based in Japan, distinguished by its focus on the life sciences sector. Capitalizing on its extensive networks within academia, the biotechnology arena, venture capital, and the pharmaceutical industry, Catalys Pacific has successfully formed a collaborative group of Strategic and Preferred Partners. This strategic approach enables the firm to develop asset-centric global bioventure companies that are dedicated to advancing innovative solutions.
As one of the largest investment firms in Japan concentrated on life sciences, Catalys Pacific is committed to addressing unmet medical needs faced by patients around the world. The firm's mission revolves around the creation and investment in companies that drive impactful innovation within the life sciences industry. Furthermore, Catalys Pacific is dedicated to maintaining a strictly independent governance structure, which allows for autonomous assessment and decision-making regarding its investments. This commitment to independence ensures that Catalys Pacific can effectively pursue its goal of fostering groundbreaking advancements in the health sector.
Industry: Venture Capital and Private Equity
Domain: http://www.catalyspacific.com/
Location: Minato-ku, Tokyo
Address: 8-14, Minami-Aoyama 3-chome, AUSPICE OMOTESANDO 4F, Minato-ku, Tokyo 107-0062, JP
Size: 2-10 employees
Company:
ChinaLink ESGt
Description: ChinaLink ESGt is a prominent venture capital firm located in Shanghai. Founded in 2007, the firm focuses on investing in late-stage seed technology companies across a diverse range of sectors, including artificial intelligence, cloud computing, biotechnology, healthcare, smart cities, renewable energy, and sustainable mobility. As the venture capital division of The Gamma Consortium, ChinaLink ESGt manages assets exceeding $5 billion, which includes the distinguished China New Era Technology Fund (CNETF).
With a commitment to staying at the forefront of innovation and investment, ChinaLink ESGt has cultivated a portfolio that features transformative companies such as Alibaba, Tencent, and SpaceX. In addition to these industry giants, the firm has also invested in groundbreaking startups like CAS and Chase Therapeutics, which are dedicated to tackling critical global challenges. ChinaLink ESGt prides itself on partnering with a diverse array of entrepreneurs, scientists, Nobel laureates, and visionaries who have established the companies that are shaping a better future. Through its focused investment strategy and deep industry knowledge, ChinaLink ESGt continues to play a vital role in advancing technological advancements and sustainable practices worldwide.
Industry: Venture Capital and Private Equity
Founded: 2007
Domain: http://www.cl-esgt.com/
Location: Shanghai
Address: BEA Tower- financial district, Shanghai, CN
Size: 11-50 employees
Company:
Chobe Capital
Description: Chobe Capital is a distinguished equity investment firm, with its headquarters situated in Shanghai, China. The company primarily concentrates on Pre-IPO and venture capital projects, positioning itself as a significant player in the investment landscape. Co-founded by notable figures such as the former General Manager of the Investment Banking Division at GUOSEN Securities, the Chairman of Jiangsu Huaxing Investment Group, and the Chairman of Shanghai AXA Group, Chobe Capital has established a foundation of expertise and leadership within the industry.
The firm prides itself on assembling a talented team with extensive experience across various sectors, including technology, media, and telecommunications (TMT), biotechnology, consumption upgrading, and environmental protection. This diverse expertise allows Chobe Capital to approach investment opportunities with a well-rounded perspective.
Chobe Capital adheres to core values of integrity, professionalism, fairness, and transparency, which guide its operations and interactions with both investors and clients. The firm is dedicated to creating value for its stakeholders by rigorously evaluating potential investment projects and prioritizing effective project management. It places strong emphasis on the importance of strategic resource connections and the careful selection of intermediary agencies, ensuring that its clients receive comprehensive support to address any weaknesses they may face.
Committed to forming long-term partnerships with both entrepreneurs and investors, Chobe Capital aims to be a trustworthy ally throughout the investment journey. The firm remains open to all potential investment opportunities, focusing particularly on sectors where it has previous experience, ultimately striving to foster growth and innovation in the businesses it supports. Through its extensive management capabilities and a commitment to high standards, Chobe Capital works tirelessly to assist clients in overcoming challenges and achieving sustainable development.
Industry: Venture Capital and Private Equity
Domain: http://www.pedaily.cn/
Location: Shanghai, Shanghai
Address: Pudong District, Yinghua Road 868, Shanghai, Shanghai 201203, CN
Size: 11-50 employees
Company:
DEFTA Partners
Description: DEFTA Partners, founded in 1985 in California, is a distinguished player in the venture capital and private equity sector. The firm has made a significant impact in identifying, investing in, and nurturing startups and individuals who are at the forefront of developing innovative technologies. Primarily focused on markets in Japan, the United States, and Europe, DEFTA Partners leverages its extensive experience and established expertise to foster growth in these regions.
With a strong international presence, DEFTA Partners has successfully expanded its operations beyond its California headquarters by establishing additional offices in Japan and Hong Kong. This strategic positioning allows the firm to maintain a broad network and gain valuable insights into emerging markets.
The firm is particularly keen on discovering promising early-stage companies within the biotechnology, pharmaceutical, and healthcare sectors. By providing the necessary support and resources, DEFTA Partners aims to fuel their growth trajectories and empower them to scale their businesses on a global level.
Industry: Venture Capital and Private Equity
Founded: 1985
Domain: http://www.deftapartners.com/
Location: San Francisco
Address: San Francisco, US
Size: 2-10 employees
Company:
Delos Capital
Description: Delos Capital is a prominent investment firm specializing in the life sciences sector, dedicated to partnering with exceptional teams that are engaged in the development of breakthrough medicines aimed at significantly enhancing the lives of patients. The firm operates as a collaborative global entity comprising seasoned biotech investors, company builders, operators, and industry analysts. Its primary objective is to provide meaningful support to the companies it invests in by delivering not only capital but also extensive biotech expertise.
Delos Capital has a proven track record in designing, building, financing, and supporting both innovative platforms and approved medications, impacting the lives of hundreds of millions around the globe. The firm is guided by a commitment to enable the creation of high-value medicines and maintains a modality-agnostic approach, working across various therapeutic areas. This enables Delos Capital to partner with a diverse range of companies, from early-stage discovery platforms to those actively engaged in clinical development.
The firm’s global team is strategically located across offices in Cambridge, Massachusetts, and East Asia, allowing them to effectively merge deep operational experiences at the heart of global biotech ventures with unique insights into innovations emerging from burgeoning biotech clusters. Through this comprehensive approach, Delos Capital continues to play a vital role in advancing life sciences and fostering advancements that promise to improve patient outcomes worldwide.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.deloscapital.com/
Location: Boston
Address: Boston, US
Size: 2-10 employees
Company:
Elevation Capital
Description: Elevation Capital is an early-stage venture fund that focuses on investing in companies with a global impact, all united by a shared vision that places humanity at the forefront of its purpose. The firm’s investment strategy is anchored in the core principle of shared value, often referred to as the "Win-Win" approach. This philosophy embodies the understanding that it is indeed possible for a company to achieve both profitable financial returns and a sustainable positive social impact simultaneously.
With team members strategically located across the United States, Canada, Europe, and the Caribbean, Elevation Capital boasts a diverse and expansive investment portfolio that reaches a variety of markets. Their areas of investment span multiple sectors, including consumer packaged goods, health and wellness, biotechnology, financial services, real estate housing solutions, hospitality, and technology.
Elevation Capital is committed to investing in bold ideas and innovative solutions that not only aim for financial success but also pave the way for a brighter and more sustainable future for society at large. Through their strategic investments, they seek to foster companies that align with their mission of leveraging profit for the greater good.
Industry: Venture Capital and Private Equity
Domain: http://www.elevationcapital.vc/
Location: Vancouver, BC
Address: Vancouver, BC V6E 1T8, CA
Size: 11-50 employees
Company:
ExSight Ventures
Description: ExSight Ventures is a distinguished venture capital firm that focuses on early-stage impact investments specifically aimed at innovative solutions in ophthalmic diagnostics and treatments. The firm is comprised of two accomplished retinal surgeons who bring their extensive medical expertise to the investment process, working alongside a dedicated team of investment professionals. Together, they have partnered to meet the growing demand for funding in early-stage companies that concentrate on ophthalmic advancements.
ExSight Ventures seeks to invest in a variety of fields, including biotechnology, medical devices, pharmaceuticals, and software solutions tailored to the ophthalmology sector. With their unique combination of medical knowledge and investment acumen, the firm is well-positioned to identify and support pioneering companies that are poised to make significant contributions to the field of eye care. For those interested in contacting ExSight Ventures for potential collaboration or inquiries, further details can be found on their official website.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.exsightventures.com/
Location: New York
Address: 1460 Broadway, New York, US
Size: 2-10 employees
Company:
FoundersX Ventures
Description: FoundersX Ventures is a prominent cross-stage venture capital firm established in 2016, with its headquarters located in Silicon Valley and an additional office in Cambridge, Massachusetts. The firm has developed a strong reputation for its expertise in investment management, focusing on a diverse range of sectors that include biotechnology, digital healthcare, enterprise software as a service (SaaS), fintech, food technology, and global supply chains.
With a commitment to identifying and nurturing the next wave of unicorns, FoundersX employs a deep-dive investment approach that leverages unique industry insights into disruptive technologies and optimal market timing. This methodology aims to deliver impressive returns on investment, thereby generating strong alpha for their stakeholders.
FoundersX Ventures is recognized as a high-value-added investor, advocating for a keen product focus alongside robust venture disciplines, particularly in deep tech companies. The firm distinguishes itself by its ability to attract long-term capital partners and establish strategic enterprise partnerships, accompanied by access to exceptional talent from leading institutions such as Stanford, UC Berkeley, MIT, and Harvard University.
As early investors in a number of tech unicorns and over 30 high-growth companies, FoundersX has demonstrated its capacity to achieve substantial returns for its investors, cementing its status as a leader in the investment management landscape. The firm continues to make significant contributions to the advancement of innovative technologies and the development of visionary enterprises.
Industry: Investment Management
Founded: 2016
Location: Menlo Park, California
Address: 3000 Sand Hill Road, Building 3, Suite 110, Menlo Park, California 94025, US
Size: 11-50 employees
Company:
FreeS Fund 峰瑞资本
Description: FreeS Fund 峰瑞资本 is a venture capital and private equity firm dedicated to investing in exceptional startups with the goal of transforming them into significant enterprises that contribute positively to society. Since its establishment in 2015, the firm has operated with a clear mission: to prioritize long-term value creation over short-term profit gains.
The firm primarily focuses on investing in early-stage and early growth-stage startups while maintaining a commitment to dedication and passion in their efforts. FreeS Fund 峰瑞资本 concentrates its investments in two key sectors—Retail and Deep Tech—while also exploring a variety of industries, including Education, Fintech, Artificial Intelligence, Biotechnology, Pharmaceuticals, New Energy, and Industry 4.0, among others.
Over the past four years, FreeS Fund has garnered recognition from esteemed institutions and media outlets such as China Venture, Zero2IPO Group, and 36Kr. These prestigious recognitions highlight the firm’s professionalism and expertise in early-stage investment and portfolio management.
Understanding the complexities of starting and nurturing new businesses, FreeS Fund 峰瑞资本 is committed to navigating the challenges of investment with resilience and integrity. The firm embraces a journey that is not without its difficulties, reflecting its dedication to choosing the right path in the pursuit of innovation and growth.
Industry: Venture Capital and Private Equity
Founded: 2015
Domain: http://www.freesvc.com/
Location: 北京, 朝阳区
Address: No.19 East Dongfang Road, 701, Block D1, Liangmaqiao DRC, 北京, 朝阳区 100600, CN
Size: 11-50 employees
Company:
GreatPoint Ventures
Description: GreatPoint Ventures is a prominent early-stage venture capital firm established by a group of entrepreneurs and operators who have collectively built companies valued at approximately $300 billion. The firm focuses its investments on Seed, Series A, and Series B rounds, typically committing between $250,000 and $20 million, with a particular emphasis on leading Series A funding. GreatPoint Ventures is dedicated to collaborating with entrepreneurs who are tackling significant challenges across several sectors, including enterprise healthcare, biotechnology, and food. The firm adopts a selective investment strategy, making fewer than ten new investments each year, which allows them to engage deeply with each team they support, fostering a strong partnership and commitment to overcoming obstacles together. Through this approach, GreatPoint Ventures aims to make a meaningful impact by empowering innovative solutions that address pressing global issues.
Industry: Venture Capital and Private Equity
Founded: 2015
Domain: http://www.gpv.com/
Location: San Francisco, CA
Address: San Francisco, CA, US
Size: 11-50 employees
Company:
HEDA VENTURES
Description: HEDA Ventures is a distinguished early-stage venture capital firm that specializes in investing in innovative and high-tech industries. With a keen focus on sectors such as biotechnology, healthcare, and frontier technology, HEDA Ventures is dedicated to supporting the growth of groundbreaking companies poised to make a significant impact in their respective fields. The firm actively seeks out opportunities to foster innovation and advance technology, demonstrating a strong commitment to nurturing ventures that are at the forefront of industry development. By strategically aligning with visionary entrepreneurs and transformative projects, HEDA Ventures plays a pivotal role in shaping the future of technology and health-related advancements.
Industry: Venture Capital and Private Equity
Founded: 2016
Domain: http://www.hedaventures.com/
Location: San Jose, California
Address: 226 Airport Pkwy, #630, San Jose, California 95110-, US
Size: 2-10 employees
Company:
Hatteras Venture Partners
Description: Hatteras Venture Partners is a notable venture capital firm that is dedicated to fostering transformational companies within various aspects of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and other related opportunities in human medicine. The firm focuses on investing in companies that are grounded in cutting-edge scientific advancements emerging from leading academic institutions. Hatteras Venture Partners has a robust investment portfolio that spans the United States, particularly in key hubs known for health innovation.
Located in the Research Triangle Park (RTP) in North Carolina, Hatteras plays a pivotal role in cultivating and supporting the growth of companies in both North Carolina and the wider Southeastern United States. This region is known for its rich technological landscape, yet it often experiences a scarcity of resident venture capital, making Hatteras's contributions even more significant.
Central to Hatteras Venture Partners' mission is a steadfast belief in the power of entrepreneurial innovation to yield valuable new products that can revolutionize medical practice and generate substantial returns for investors. The team at Hatteras, composed of experienced entrepreneurs, operators, and investors, is committed to the prosperity of the companies in its portfolio as well as the dedicated individuals who drive these enterprises forward.
Founded in 2000 and headquartered in Durham, North Carolina, Hatteras Venture Partners boasts a seasoned team with diverse and complementary skill sets that are especially relevant for building successful biomedical companies. The firm leverages its operational expertise, proven track record, and ability to enhance the value of its investments to support the growth and success of its portfolio companies. With five funds under its management, Hatteras oversees approximately $450 million in assets.
Beyond its investment activities, Hatteras Venture Partners is an Innovation to Impact sponsor of the Council for Entrepreneurial Development, a member of NCBIO, and an engaged volunteer supporter of biotech initiatives in North Carolina and the southeastern region. This involvement underscores the firm’s commitment to advancing biotech activities and fostering a thriving entrepreneurial ecosystem in the area.
Industry: Venture Capital and Private Equity
Founded: 2000
Domain: http://www.hatterasvp.com/
Location: Durham, NC
Address: Durham, NC 27701, US
Size: 11-50 employees
Company:
Hemi Ventures
Description: Hemi Ventures is a venture capital and private equity firm that focuses on investing in early-stage startups operating within the innovative realms of autonomous vehicles, artificial intelligence applications, robotics, biotechnology, and various other emerging technology sectors. The firm is dedicated to forming strategic partnerships with entrepreneurs who are at the forefront of their industries, fostering groundbreaking innovations that have the potential to unlock new opportunities and enhance human capabilities. Hemi Ventures supports these pioneering tech leaders as they navigate uncharted market landscapes and strive to advance the industry, effectively addressing the challenges and limitations that currently exist. Through their investments, Hemi Ventures plays a crucial role in propelling transformative solutions that seek to redefine the future.
Industry: Venture Capital and Private Equity
Founded: 2016
Domain: http://www.hemi.vc/
Location: Palo Alto, California
Address: 228 Hamilton Ave, 3rd Floor, Palo Alto, California 94301, US
Size: 2-10 employees
Company:
IntuitiveX
Description: IntuitiveX is an AI-first medical innovation incubator and consultancy that focuses on intellectual property and commercialization services. The firm is dedicated to fostering growth in companies at all stages of development within the medical devices, biotechnology, pharmaceuticals, and digital health sectors. By leveraging their expertise in intellectual property and commercialization, IntuitiveX is adept at discovering and unlocking the potential of groundbreaking ideas. They utilize their extensive network and resources to support the realization of these ideas, making it possible for innovative companies to thrive in a competitive marketplace. IntuitiveX’s commitment to innovation positions them as a valuable partner in the advancement of medical technology and healthcare solutions.
Industry: Venture Capital and Private Equity
Founded: 2017
Domain: http://www.intuitivex.com/
Location: Seattle, Washington
Address: 1730 Minor Ave, Ste 1050, Seattle, Washington 98101, US
Size: 2-10 employees